[2]ASANO R, KUDO T, MAKABE K, et al. Antitumor activity of interleukin21 prepared by novel refolding procedure from inclusion bodies expressed in Escherichia coli[J]. FEBS Lett, 2002,528(1/3):70.
[3]BRENNE AT, BAADE RO T, WAAGE A, et al. Interleukin21 is a growth and survival factor for human myeloma cells[J]. Blood, 2002,99(10):3756.
[4]KASAIAN M T, WHITTERS M J, CARTER L L, et al. IL21 limits NK cell responses and promotes antigenspecific T cell activation: a mediator of the transition from innate to adaptive immunity[J]. Immunity, 2002,16(4):559569.
[5]付强,钱冬萌,闫志勇,等. IL21编码基因的克隆及其在大肠杆菌中的表达[J]. 青岛大学医学院学报, 2003,39(1):1517.
[6]BONDENSGAARD K, BREINHOLT J, MADSEN D, et al. The existence of multiple conformers of interleukin21 directs engineering of a superpotent analogue[J]. J Biol Chem, 2007,282(32):2332623336.
[7]BAAN C C, BALK A H, DIJKE IE, et al. Interleukin21: an interleukin2 dependent player in rejection processes[J]. Transplantation, 2007,83(11):14851492.
百度搜索“70edu”或“70教育网”即可找到本站免费阅读全部范文。收藏本站方便下次阅读,70教育网,提供经典医药类大肠杆菌表达人IL21融合蛋白的纯化和抗原性分析(3)在线全文阅读。
相关推荐: